Surescripts has applied to become a Qualified Health Information Network, through its subsidiary Surescripts Health Information Network, furthering its commitment to the Trusted Exchange Framework and Common Agreement and advancing interoperability to benefit all participants in the Surescripts Network Alliance and the patients they serve.
“Surescripts is delivering interoperability that empowers clinicians, alleviating some of the most frustrating burdens they face today,” said Frank Harvey, CEO of Surescripts. “Interoperability means helping clinicians to close gaps in patient information, improve safety and support less costly care. Most importantly, interoperability means stronger, trusted relationships between patients and care providers.”
“Applying to become a QHIN is an important next step that illustrates Surescripts ongoing commitment to advancing interoperability across the healthcare industry. We look forward to working with the Office of the National Coordinator for Health Information Technology, The Sequoia Project and all Network Alliance participants to ensure patients have access to quality, safe and less costly care no matter where they live and providers are able to give that care to their patients in the most meaningful way possible,” Harvey said.
Surescripts established electronic prescribing nation-wide two decades ago, revolutionizing health care. Today, Surescripts has evolved to deliver nationwide interoperability at scale with more than 21.7 billion transactions in 2022, bringing patient-specific benefit and clinical information to the fingertips of more than 2 million care providers, covering virtually every American patient.
In practice, interoperability means delivering clinicians 2.5 billion medication histories and 1.25 billion links to clinical documents at the point of care in 2022, through the Surescripts network.
The Surescripts Network Alliance includes nearly all electronic health records vendors, pharmacy benefit managers, pharmacies and clinicians, plus health plans, long-term and post-acute care organizations, patient access vendors and specialty pharmacy organizations.